Log in

NYSE:BAX - Baxter International Stock Price, Forecast & News

$79.79
-0.38 (-0.47 %)
(As of 03/29/2020 02:08 AM ET)
Today's Range
$76.37
Now: $79.79
$80.67
50-Day Range
$71.57
MA: $85.37
$93.30
52-Week Range
$69.10
Now: $79.79
$95.00
Volume4.45 million shs
Average Volume4.86 million shs
Market Capitalization$40.47 billion
P/E Ratio24.11
Dividend Yield1.10%
Beta1
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Read More
Baxter International logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.36 billion
Cash Flow$4.95 per share
Book Value$15.50 per share

Profitability

Net Income$1.00 billion

Miscellaneous

Employees50,000
Market Cap$40.47 billion
Next Earnings Date4/23/2020 (Estimated)
OptionableOptionable

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.


Baxter International (NYSE:BAX) Frequently Asked Questions

How has Baxter International's stock been impacted by COVID-19 (Coronavirus)?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BAX shares have increased by 2.3% and is now trading at $79.79. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Baxter International?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Baxter International.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, April 23rd 2020. View our earnings forecast for Baxter International.

How were Baxter International's earnings last quarter?

Baxter International Inc (NYSE:BAX) announced its quarterly earnings data on Tuesday, March, 17th. The medical instruments supplier reported $0.97 EPS for the quarter, beating the Zacks' consensus estimate of $0.88 by $0.09. The medical instruments supplier had revenue of $2.85 billion for the quarter, compared to analysts' expectations of $2.87 billion. Baxter International had a net margin of 9.12% and a return on equity of 22.41%. The firm's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.80 EPS. View Baxter International's earnings history.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be given a dividend of $0.22 per share on Wednesday, April 1st. This represents a $0.88 annualized dividend and a dividend yield of 1.10%. The ex-dividend date is Thursday, February 27th. View Baxter International's dividend history.

How will Baxter International's stock buyback program work?

Baxter International announced that its board has authorized a stock buyback plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 6.1% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's management believes its shares are undervalued.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its first quarter earnings guidance on Tuesday, March, 17th. The company provided earnings per share guidance of $0.72-0.74 for the period, compared to the Thomson Reuters consensus estimate of $0.81.

What price target have analysts set for BAX?

19 Wall Street analysts have issued 1 year price objectives for Baxter International's shares. Their forecasts range from $75.00 to $104.00. On average, they anticipate Baxter International's stock price to reach $92.89 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price. View analysts' price targets for Baxter International.

Has Baxter International been receiving favorable news coverage?

News articles about BAX stock have been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Baxter International earned a news impact score of -2.1 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutBaxter International.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 6,344,100 shares, an increase of 27.9% from the February 27th total of 4,960,000 shares. Based on an average daily trading volume, of 2,620,000 shares, the short-interest ratio is presently 2.4 days. Currently, 1.3% of the shares of the stock are sold short. View Baxter International's Current Options Chain.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Honeywell International (HON), Johnson & Johnson (JNJ), Cisco Systems (CSCO), AT&T (T), BlackRock (BLK), Pfizer (PFE), Verizon Communications (VZ), Alibaba Group (BABA) and Home Depot (HD).

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
  • Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 48)
  • Mr. Scott Pleau, Sr. VP of Operations (Age 53)

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different retail and institutional investors. Top institutional investors include Wealth Quarterback LLC (14.07%), State Street Corp (4.68%), Third Point LLC (3.43%), FMR LLC (2.64%), Geode Capital Management LLC (1.41%) and Nuveen Asset Management LLC (1.40%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View institutional ownership trends for Baxter International.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bessemer Group Inc., Schroder Investment Management Group, Bank of New York Mellon Corp, AQR Capital Management LLC, Janus Henderson Group PLC, Los Angeles Capital Management & Equity Research Inc., and Argent Capital Management LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Jacqueline Kunzler, James R Gavin III, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc, and Thomas T Stallkamp. View insider buying and selling activity for Baxter International.

Which major investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Norges Bank, Capital International Investors, Nuveen Asset Management LLC, Bank of Montreal Can, Third Point LLC, Alyeska Investment Group L.P., and New York State Common Retirement Fund. View insider buying and selling activity for Baxter International.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $79.79.

How big of a company is Baxter International?

Baxter International has a market capitalization of $40.47 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe. View additional information about Baxter International.

What is Baxter International's official website?

The official website for Baxter International is http://www.baxter.com/.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


MarketBeat Community Rating for Baxter International (NYSE BAX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  670 (Thanks for Voting!)
Underperform Votes:  589 (Thanks for Voting!)
Total Votes:  1,259
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: Percentage Decliners

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel